
Peter R. Galle, MD, PhD, Mainz University Medical Center
Advertisement
Articles by Peter R. Galle, MD, PhD, Mainz University Medical Center















Discussion around topics pertaining to the use of systemic therapy in advanced liver cancer. Topics will include the latest research in the field and the impact of recent clinical trials on making decisions around treatment selection.















Advertisement
Latest Updated Articles
Screening Vs Diagnosis: Assessing Liver FunctionOctober 30th 2020
Immunotherapy Monotherapy in Later-Line SettingOctober 30th 2020
Frontline I/O: Clinical Trial OverviewsJune 29th 2020
R/R HCC: Second-Line OptionsJune 29th 2020
REACH and REACH2 Trial OverviewJune 29th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Sonesitatug Vedotin in CLDN18.2+ Gastroesophageal Cancer
2
Dose Optimization, Evidentiary Bars, and Patient Selection Shape Trial Design in EGFR- and HER2-Mutant NSCLC
3
EC Approves Extended Cemiplimab Dosing in Skin, Lung, and Cervical Cancers
4
Defining High-Risk Localized Prostate Cancer and the DASL-HiCaP Trial
5

